As artificial intelligence tools flood the healthcare market, telehealth pioneer Amwell is making a strategic bet that health plans and employers will pay for a unified platform to manage the chaos. The company argues that the explosion of AI-powered point solutions is creating vendor sprawl and member confusion—problems its integrated infrastructure is uniquely positioned to solve.

"We are building the trusted platform where AI-powered care runs," CEO Ido Schoenberg told investors during the company's third-quarter earnings call, framing Amwell not as a standalone telehealth provider but as essential infrastructure for AI-enabled care delivery.

Financial Performance Shows Stabilization Despite Revenue Decline

Amwell reported third-quarter 2024 revenue of $49 million, representing a 12.9% year-over-year decline but exceeding guidance by $1 million. The company dramatically narrowed its losses, posting a net loss of $11.7 million compared to $29.3 million in the same quarter last year. Adjusted EBITDA loss improved to $3.6 million from $12.7 million year-over-year.

The company raised its full-year 2024 revenue guidance to $204-206 million from $195-205 million, and improved its adjusted EBITDA loss forecast to $6.9-7.9 million from a projected $12-16 million loss. Management expects to achieve positive operating cash flow and breakeven-to-positive adjusted EBITDA in the fourth quarter of 2024.

Subscription revenue declined 22.5% year-over-year to $23.9 million, reflecting previously disclosed customer churn. The platform continues to serve more than 90 million covered lives through health plans and employers, plus 9.6 million Military Health System beneficiaries.

Government Contracts and Engagement Strategy Drive Growth Thesis

Amwell's growth strategy centers on major government healthcare contracts and what it calls "always-on engagement" that drives utilization rates three times higher than typical health plan implementations, which see only single-digit engagement.

The Department of Veterans Affairs issued a letter of intent for enterprise-wide platform deployment, though this does not yet constitute a binding contract. The company's Defense Health Agency contract comes up for renewal in August 2025, with negotiations underway for a longer-term arrangement. Amwell cited its interoperability capabilities and cybersecurity compliance as factors in the VA's evaluation.

Visit metrics showed mixed results: Amwell Medical Group paid visits remained flat year-over-year at 301,000, while virtual primary care visits jumped 41%. Total platform visits declined 30.5% to 760,000, which the company attributed to portfolio changes.

Platform Consolidation as Antidote to AI Fragmentation

Amwell's core argument positions its platform as the solution to what it characterizes as an unsustainable proliferation of disconnected AI health tools. By offering unified integration, consistent member experience, and common data architecture for outcomes measurement, the company aims to reduce integration costs while enabling health plans to track return on investment across multiple point solutions.

The strategy emphasizes "clinicians in the loop" rather than autonomous AI, positioning Amwell as infrastructure that other AI-powered solutions run on top of rather than a competing standalone product. This approach creates both partnership opportunities and competitive pressure for independent AI health companies seeking health plan distribution.

CEO Schoenberg indicated the company may shift from fixed software-as-a-service fees toward outcomes-based arrangements with shared savings, reflecting broader industry movement toward value-based payment models in digital health.

Whether health plans will consolidate around platform providers or continue managing multiple vendor relationships remains to be seen, but Amwell's financial stabilization and government contract momentum suggest at least some market validation for the unified infrastructure thesis.

Sources

  1. Amwell bets AI boom will boost demand for its unified care platform — Fierce Healthcare